
<ns0:uwmetadata xmlns:ns0="http://phaidra.univie.ac.at/XML/metadata/V1.0" xmlns:ns1="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0" xmlns:ns10="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0" xmlns:ns11="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0/entity" xmlns:ns12="http://phaidra.univie.ac.at/XML/metadata/digitalbook/V1.0" xmlns:ns13="http://phaidra.univie.ac.at/XML/metadata/etheses/V1.0" xmlns:ns2="http://phaidra.univie.ac.at/XML/metadata/extended/V1.0" xmlns:ns3="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/entity" xmlns:ns4="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/requirement" xmlns:ns5="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/educational" xmlns:ns6="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/annotation" xmlns:ns7="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/classification" xmlns:ns8="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/organization" xmlns:ns9="http://phaidra.univie.ac.at/XML/metadata/histkult/V1.0">
  <ns1:general>
    <ns1:identifier>o:35099</ns1:identifier>
    <ns1:title language="en">Potential Influence of miR-204-3P on ETS-1 Protein Expression in Papillary Thyroid Carcinoma</ns1:title>
    <ns2:alt_title language="sr">Potencijalni uticaj mikroRNK-204-3p na ekspresiju ETS-1 proteina u papilarnom tiroidnom karcinomu</ns2:alt_title>
    <ns1:language>en</ns1:language>
    <ns1:description language="en">ABSTRACT
Objectives: ETS-1 (E26 transformation-specific) is a transcription factor associated with the progression of carcinomas of various origins. Its expression in PTC is poorly described, and the findings are controversial. This study aimed to describe ETS-1 protein expression in papillary thyroid carcinoma (PTC) and to evaluate the potential influence of miR-204-3p on the ETS-1 protein expression in PTC since the bioinformatic analysis revealed that miR-204-3p shares a seed sequence with the 3’-untranslated region (3’UTR) of ETS-1 mRNA.</ns1:description>
    <ns1:keyword language="en">ETS-1 protein expression, papillary thyroid carcinoma (PTC)</ns1:keyword>
    <ns2:identifiers>
      <ns2:resource>1552099</ns2:resource>
      <ns2:identifier>10.1530/endoabs.101.PS3-24-05</ns2:identifier>
    </ns2:identifiers>
    <ns2:identifiers>
      <ns2:resource>1552101</ns2:resource>
      <ns2:identifier>1470-3947</ns2:identifier>
    </ns2:identifiers>
  </ns1:general>
  <ns1:lifecycle>
    <ns1:upload_date>2024-11-08T10:59:25.853Z</ns1:upload_date>
    <ns1:status>44</ns1:status>
    <ns2:peer_reviewed>yes</ns2:peer_reviewed>
    <ns1:contribute seq="0">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Stefana</ns3:firstname>
        <ns3:lastname>Stojanović</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute for the Application of Nuclear Energy INEP, Serbia</ns3:institution>
        <ns3:orcid>0000-0003-3808-0467</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="1">
        <ns3:firstname>Tijana</ns3:firstname>
        <ns3:lastname>Išić Denčić</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute for the Application of Nuclear Energy INEP, Serbia</ns3:institution>
        <ns3:title1>doktor bioloških nauka</ns3:title1>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0001-8475-2266</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="2">
        <ns3:firstname>Marija</ns3:firstname>
        <ns3:lastname>Milinković</ns3:lastname>
        <ns3:institution>Clinical Center of Serbia, Department of Pathology, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="3">
        <ns3:firstname>Katarina</ns3:firstname>
        <ns3:lastname>Tausanović</ns3:lastname>
        <ns3:institution>Clinical Center of Serbia, Clinic for Endocrine Surgery, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="4">
        <ns3:firstname>Jelena</ns3:firstname>
        <ns3:lastname>Janković Miljuš</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute for the Application of Nuclear Energy INEP, Serbia</ns3:institution>
        <ns3:title1>doktor biohemijskih nauka</ns3:title1>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0002-2589-3306</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="5">
        <ns3:firstname>Ilona</ns3:firstname>
        <ns3:lastname>Đorić</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute for the Application of Nuclear Energy INEP, Serbia</ns3:institution>
        <ns3:title1>doktor bioloških nauka</ns3:title1>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0001-5322-4559</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="6">
        <ns3:firstname>Sonja</ns3:firstname>
        <ns3:lastname>Šelemetjev</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute for the Application of Nuclear Energy INEP, Serbia</ns3:institution>
        <ns3:title1>doktor bioloških nauka</ns3:title1>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0002-2898-6671</ns3:orcid>
      </ns1:entity>
    </ns1:contribute>
  </ns1:lifecycle>
  <ns1:technical>
    <ns1:format>application/pdf</ns1:format>
    <ns1:size>64620</ns1:size>
    <ns1:location>https://phaidrabg.bg.ac.rs/o:35099</ns1:location>
  </ns1:technical>
  <ns1:rights>
    <ns1:cost>no</ns1:cost>
    <ns1:copyright>yes</ns1:copyright>
    <ns1:license>16</ns1:license>
  </ns1:rights>
  <ns1:classification>
    <ns1:purpose>70</ns1:purpose>
  </ns1:classification>
  <ns1:organization>
    <ns8:hoschtyp>92000004</ns8:hoschtyp>
    <ns8:orgassignment>
      <ns8:faculty>11A29</ns8:faculty>
    </ns8:orgassignment>
  </ns1:organization>
  <ns12:digitalbook>
    <ns12:name_magazine language="en">Endocrine Abstracts-46th Annual Meeting of the European Thyroid Association (ETA) 2024</ns12:name_magazine>
    <ns12:volume>101</ns12:volume>
    <ns12:publisher>Bioscientifica</ns12:publisher>
    <ns12:releaseyear>2024</ns12:releaseyear>
  </ns12:digitalbook>
</ns0:uwmetadata>
